Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Moodys
Merck
McKesson
Dow
Medtronic
McKinsey

Last Updated: June 9, 2023

Litigation Details for Plaintiff(s) v. Defendant(s) (D. Del. 2019)


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Small Molecule Drugs cited in Plaintiff(s) v. Defendant(s)
Biologic Drugs cited in Plaintiff(s) v. Defendant(s)
The biologic drug covered by the patents cited in this case is ⤷  Try a Trial .

Details for Plaintiff(s) v. Defendant(s) (D. Del. 2019)

Date Filed Document No. Description Snippet Link To Document
2020-10-07 1131 Complaint United States Patent Nos. 10,617,698 (“the ’698 Patent”), 10,660,908 (“the ’908 Patent”), 10,682,36410,682,364 (“the ’364 Patent”), 10,688,108 (“the ’108 Patent”), and 10,716,799 (“the ’799 Patent”) (collectively… This is a civil action for patent infringement arising under the patent laws of the United States, … This is a civil action for patent infringement arising under the patent laws of the United States, …are covered by claims of the Patents-in-Suit. 22. The Patents-in-Suit are listed in Approved External link to document
2018-09-21 1168 prior to the expiration of U.S. Patent No. 9,957,232 (the “’232 patent”). As set forth in its… The ’232 Patent 25. U.S. Patent No. 9,957,232, entitled “… 1. This is an action for patent infringement under the patent laws of the United States, Title…forth in greater detail in the ’232 patent, the claims of the ’232 patent, incorporated by reference herein…the ’232 patent. 31. Apotex had knowledge of the claims of the ’232 patent before External link to document
0000-00-00 1802 Complaint antibody in U.S. Patent No. 9,079,949 (“the ’949 patent”). 23. The ’949 patent is entitled “Anti-C5…pending patent applications, by the patent asserted in the 18-cv-1802 case, and by U.S. Patent No. 10,…,472,623 (“the ’623 patent” or “the Patent-in-Suit”). A copy of the ’623 patent is attached hereto as…623 patent from issuing. During prosecution of the patent application that led to the ’623 patent, an… THE PATENT-IN-SUIT U.S. Patent No. 10,472,623 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Johnson and Johnson
Moodys
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.